论文部分内容阅读
为探讨缺血性、出血性脑血管病患者的血小板功能变化,本文检测了脑梗塞和脑出血患者血小板膜表面及血浆内α颗粒膜蛋白（GMP-140）及血浆TXB_2、6-Keto-PGF_（1α）的变化。 对象和方法 一、对象: （一）正常对照组:30例（男18,女12）,平均年龄56.4岁。 （二）脑梗塞组:30例（男20,女10）,平均年龄58.6岁。 （三）脑出血组:25例（男19,女6）,平均年龄55.8岁。以上病例参照第二次全国脑血管病学术会议第三次修订标准。 二、试剂与仪器:
In order to investigate the changes of platelet function in patients with ischemic hemorrhagic cerebrovascular disease, the effects of GMP-140 and plasma TXB_2, 6-Keto-PGF_ (1α) changes. Subjects and methods First, the object: (a) normal control group: 30 cases (male 18, female 12), with an average age of 56.4 years old. (B) cerebral infarction group: 30 cases (20 men and 10 women), with an average age of 58.6 years. (C) cerebral hemorrhage group: 25 cases (19 male and 6 female), the average age of 55.8 years old. More reference to the second case of the National Cerebrovascular Disease Conference of the third revision of the standard. Second, reagents and equipment: